Resources

1 Resources for

bgc 945

Subscribe to this listing via:
RSS
Email

BNET Resources

Onyx's $320M Bet on BTG's Anticancer Compound: Eben Tessari submits: BTG has granted the worldwide commercialization and development rights of BGC 945, a novel anticancer compound, to Onyx ONXX in exchange for a potential $320M. BGC 945 is a novel compound that inhibits thymidylate synthase (TS), an enzyme involved in cell growth and division. However,...; Tags: Compound, Onyx Software, Cell, Seeking Alpha, Eben Tessari, BGC 945, Onyx Pharmaceuticals Inc., Healthcare; External links 2008-11-10

<< Previous
page 1 of 1
Next >>

Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors

Your Work The 7 Interview Questions You Must Ask

The 7 Interview Questions You Must Ask

Forget 'What are your strengths and weaknesses?' If you want to get the real dope on prospective employees, ask job candidates these seven questions.
Your Industry Congress Looks at Getting Into the Weather Business

Congress Looks at Getting Into the Weather Business

Geoengineering — the concept of deliberately manipulating the earth’s climate system to counteract climate change — made its debut in Congress this week, which I suppose makes it officially “mainstream.” The House’s Committee on Science and Technology held a hearing on geoengineering — the first serious congressional review of the subject, according to committee chairman Rep. [...]
Your Money 29 Fees We Hate Most

29 Fees We Hate Most

An increasing number of businesses, from hotels to cell phone providers, are advertising bargain prices and then tacking on hidden fees and charges to boost the final cost. Here’s how you can fight back.